Viw Magazine

Men's Weekly

.

Constantly Strategical Planning High-Growth Sectors, Grand Pharma’s 2022 Interim Results Continue to Grow

  • Written by Viw Magazine

HONG KONG SAR - Media OutReach - 11 August 2022- Grand Pharma (0512.HK, the "Company") announced its 2022 interim results recently. During the first half of 2022 (the "Period"), the Company recorded revenue of approximately HKD 5.21 billion, representing an increase of 14.1% YoY; net profit attributable to owners of the company of HKD 1.09 billion (excluding the changes in investment in Telix), representing an increase of 20.1% YoY.

Read more

LifeStyle

Why Hurstville Tutoring Supports Strong Academic Growth And Confidence

Students in academically competitive areas often face increasing pressure to perform well across m...

Is a Pop Top Caravan Suitable for a Family of Four?

For families planning road trips across Australia, choosing the right caravan layout can shape the...

The Structural Foundation of Secure and Refined Entrances: Gate Hardware

A gate often forms the first point of contact between a property and the outside world. Its presen...

Considering Combined Surgical Approaches for Natural-Looking Results

Cosmetic procedures are no longer viewed as single, isolated treatments. Many individuals explorin...